APA (7th ed.) Citation

H, M., M, M., D, I., H, K., T, F., T, I., & T, S. (2026). Ulcerative Colitis after Administration of Dupilumab, an Anti-interleukin-4 Receptor Subunit α Monoclonal Antibody. Internal medicine (Tokyo, Japan), 65(11), 1505. https://doi.org/10.2169/internalmedicine.5953-25

Chicago Style (17th ed.) Citation

H, Mamizu, Mamizu M, Ishikawa D, Kawakami H, Furukawa T, Ishida T, and Sakai T. "Ulcerative Colitis After Administration of Dupilumab, an Anti-interleukin-4 Receptor Subunit α Monoclonal Antibody." Internal Medicine (Tokyo, Japan) 65, no. 11 (2026): 1505. https://doi.org/10.2169/internalmedicine.5953-25.

MLA (9th ed.) Citation

H, Mamizu, et al. "Ulcerative Colitis After Administration of Dupilumab, an Anti-interleukin-4 Receptor Subunit α Monoclonal Antibody." Internal Medicine (Tokyo, Japan), vol. 65, no. 11, 2026, p. 1505, https://doi.org/10.2169/internalmedicine.5953-25.